Medidrug® OSD S
Lyophilized reference material, based on serum, for quality assurance of the determination of opioid substitution drugs. The indicated target values are determined by independent accredited laboratories (EN ISO 17025).
The analyses were performed according to the guidelines of the German Medical Association for Quality Assurance (RiliBÄK) and the guidelines of the GTFCh (Society of Toxicological and Forensic Chemistry in Germany).
Our controls are also available in a set, containing a blank serum (L0) for method validation or base line determination; all control levels and blank matrices in serum share the same serum matrix. Product group overview | ||||||
Serum | ||||||
Medidrug® | OSD S | |||||
8 analytes | ||||||
L0 | L1 | L2 | L3 | L4 | ||
Analyte | Unit | target values | ||||
Buprenorphine | µg/L | < 0,2 | 1 | 5 | 10 | 20 |
Norbuprenorphine | µg/L | < 0,2 | 3 | 5 | 10 | 25 |
Methadone | µg/L | < 2,0 | 10 | 50 | 100 | 200 |
EDDP | µg/L | < 2,2 | 10 | 50 | 100 | 200 |
6-MAM | µg/L | < 0,5 | 5 | 10 | 20 | 60 |
Morphine | µg/L | < 1,3 | 10 | 50 | 100 | 200 |
Codeine | µg/L | < 1,3 | 25 | 50 | 100 | 200 |
Dihydrocodeine | µg/L | < 1,1 | 25 | 100 | 300 | 500 |
Medidrug® OSD VB
Lyophilized reference material, based on whole blood, for quality assurance of the determination of opioid substitution drugs. The indicated target values are determined by independent accredited laboratories (EN ISO 17025).
The analyses were performed according to the guidelines of the German Medical Association for Quality Assurance (RiliBÄK) and the guidelines of the GTFCh (Society of Toxicological and Forensic Chemistry in Germany).
Our controls are also available in a set, containing a blank whole blood (L0) for method validation or base line determination; all control levels and blank matrices in whole blood share the same whole blood matrix. Product group overview | |||||
Whole blood | |||||
Medidrug® | OSD VB | ||||
8 analytes | |||||
L0 | L1 | L2 | L3 | ||
Analyte | Unit | target values | |||
Buprenorphine | µg/L | < 0,1 | 1 | 20 | 50 |
Norbuprenorphine | µg/L | < 0,2 | 5 | 20 | 50 |
Methadone | µg/L | < 1,0 | 25 | 100 | 200 |
EDDP | µg/L | < 0,8 | 25 | 100 | 200 |
6-MAM | µg/L | < 0,2 | 5 | 25 | 50 |
Morphine | µg/L | < 0,2 | 10 | 50 | 200 |
Codeine | µg/L | < 0,2 | 25 | 50 | 200 |
Dihydrocodeine | µg/L | < 0,3 | 50 | 200 | 500 |
Medidrug® OSD U
Lyophilized urine-based reference material for quality assurance of the determination of opioid substitution drugs.
The indicated target values are determined by independent accredited laboratories (EN ISO 17025); the analyses were performed according to the guidelines of the German Medical Association of Quality Assurance (RiliBÄK) and the guidelines of the GTFCh (Society of Toxicological and Forensic Chemistry in Germany).
Medidrug® Basis-line U
Lyophilized reference material for base line determination in different applications or as negative control.
Product group overview | ||||||
Urine | | |||||
Medidrug® | OSD U | Basis-line U | ||||
8 analytes | 71 analytes (excerpt) | |||||
L1 | L2 | L3 | L4 | Negative | ||
Analyte | Unit | target values | ||||
Buprenorphine | µg/L | 5 | 20 | 50 | 300 | <LOD |
Norbuprenorphine | µg/L | 5 | 50 | 100 | 300 | <LOD |
Methadone | µg/L | 45 | 90 | 200 | 500 | <LOD |
EDDP | µg/L | 45 | 90 | 200 | 500 | <LOD |
6-MAM | µg/L | 5 | 10 | 25 | 100 | <LOD |
Morphine | µg/L | 10 | 25 | 100 | 500 | <LOD |
Codeine | µg/L | 10 | 25 | 100 | 500 | <LOD |
Dihydrocodeine | µg/L | 25 | 50 | 100 | 500 | <LOD |
|